Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response

Eitemau Tebyg

• Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response
  gan: Margaret Folaron, et al.
  Cyhoeddwyd: (2019-07-01)
• Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer
  gan: Bothwell, Katelyn D., et al.
  Cyhoeddwyd: (2016)
• Vascular Priming Enhances Chemotherapeutic Efficacy against Head and Neck Cancer
  gan: Folaron, Margaret, et al.
  Cyhoeddwyd: (2013)
• Establishment and Characterization of Patient Tumor-Derived Head and Neck Squamous Cell Carcinoma Xenografts
  gan: Seshadri, Mukund, et al.
  Cyhoeddwyd: (2009)
• Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts
  gan: Cao, Shousong, et al.
  Cyhoeddwyd: (2011)